Supported byOwner's Engineer
Clarion Energy banner

Pharmaceutical Industry

Supported byClarion Owner's Engineer

pharma

Healthy Investment

 

  • – The value of sector annual production is Eur 308 mill.
  • – Generic drugs development strategy
  • – Cost efficiency & intellectual capacities
  • – Market potentials & commitment to quality

 

Supported by

Serbia Business produced several briefs on market status covering producers, distributors and local outsourced partners. Pharma sector in Serbia is one of the most perspective business areas.

Serbia Business also produced 2011/2010 pharma sector market report.

More on sector opportunities

Supported by
Previous article
Next article

RELATED ARTICLES

Supported byClarion Energy
ElevatePR Serbia
Serbia Energy News
error: Content is protected !!